Published guidance, NICE advice and quality standards | Guidance

Showing 521 to 530 of 875

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes	TA572	27 March 2019	27 March 2019
Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer	TA569	20 March 2019	20 March 2019
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)	TA570	20 March 2019	20 March 2019
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib	TA571	20 March 2019	20 March 2019
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal)	TA568	13 March 2019	13 March 2019
Cochlear implants for children and adults with severe to profound deafness	TA566	7 March 2019	7 March 2019
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer	TA563	27 February 2019	27 February 2019
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia	TA561	27 February 2019	27 February 2019
Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanoma	TA562	27 February 2019	27 February 2019
Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal)	TA560	20 February 2019	20 February 2019